Back to mobile site

Cubist Pharmaceuticals (CBST) to Promote AstraZeneca's MERREM I.V. in the U.S.

July 2, 2008 7:48 AM EDT Send to a Friend
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login